- FDA Approves Landmark Sickle Cell Gene Therapies
- Hospitals in Ukraine Seeing Surge in Drug-Resistant Infections: CDC
- Women With Very Early Breast Cancer May Safely Skip Radiation Rx: Study
- Can Breast Cancer Survivors Reduce Frequency of Mammograms?
- Lymphedema Left her ‘Miserable, Depressed’ Until Specialized Surgery Changed Everything
- Night Shifts Are Triggering Sleep Disorders in Workers
- Diabetes Meds Like Ozempic, Mounjaro Might Also Lower Risks for Colon Cancer
- Suicide Rates Have Risen Steadily for Black Girls and Women
- White House Could Punish Big Pharma’s High Prices by Removing Patents
- Biden Administration Delays Decision on Menthol Cigarette Ban Amid Pushback
Longer Detox Might Work Better for Prescription Pain Med Addiction

WEDNESDAY, Oct. 23A longer period of detoxification may be more effective for people being treated for addiction to prescription painkillers called opioids, according to a small new study.
Abuse of prescription opioids such as oxycodone, hydrocodone and hydromorphone is a major public health problem in the United States. The new 12-week study, which included 70 people undergoing outpatient treatment for opioid addiction, was published online Oct. 23 in the journal JAMA Psychiatry.
For the first two weeks, all the patients took buprenorphine, a medication used to treat opioid addiction. They were then randomly assigned to slowly reduce the dose of buprenorphine over one, two or four weeks, followed by treatment with naltrexone, a medication that blocks opioid strength.
Patients in the four-week group were more likely to stop abusing opioids than those in the one-week or two-week groups, according to a journal news release.
The findings suggest that some prescription opioid abusers may respond positively to outpatient treatment with buprenorphine detoxification followed by naltrexone while undergoing behavioral therapy [counseling], study authors wrote.
“Additional controlled studies are needed to better understand the parameters of efficacious treatments for [prescription opioid] dependence, as well as to identify the individuals for whom brief vs. longer-term treatments are warranted,” concluded study authors Stacey Sigmon, of the University of Vermont, in Burlington, and colleagues.
More information
The U.S. National Institute on Drug Abuse has more about prescription drug abuse.
Source: HealthDay
Copyright © 2023 HealthDay. All rights reserved.